![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 26, 2019 7:39:19 PM
https://www.investors.com/news/technology/amgen-stock-dips-deal-buy-celgene-drug-otezla/
How Otezla works
Though many people assume that plaque psoriasis is just a skin disease, it actually starts inside the body—so it’s important to keep that in mind.
Plaque psoriasis is associated with overactive inflammation in the body. Lab research has shown that an enzyme called phosphodiesterase 4 (PDE4), located inside cells, contributes to this inflammation.
“Otezla works from the inside to help reduce inflammation.”
-Dr. Erin Boh, board certified dermatologist
Otezla is called a PDE4 inhibitor—meaning it works inside inflammatory cells to reduce PDE4 activity. A reduction in PDE4 activity is thought to help reduce the overactive inflammation that happens in people with plaque psoriasis
https://www.otezla.com/plaque-psoriasis-treatment/mechanism-of-action
A key aspect of Brilacidin's mechanism of action, inhibiting Phosphodiesterase 4 (PDE4), may further support its use in treating Asthma, Psoriasis, Psoriatic Arthritis and Chronic Obstructive Pulmonary Disease (COPD), alongside other chronic autoimmune conditions.
http://www.ipharminc.com/brilacidin-1
Brilacidin is being developed as a novel, non-corticosteroid, non-biologic treatment, with formulation plans including oral tablets
http://www.ipharminc.com/press-release/2019/6/6/innovation-pharmaceuticals-signs-agreement-for-advanced-oral-tablet-technology-in-treating-inflammatory-bowel-disease?rq=tablet
So, a key aspect of Brilacidin's mechanism of action, inhibiting Phosphodiesterase 4 (PDE4), may further support its use in treating Asthma, Psoriasis, Psoriatic Arthritis and Chronic Obstructive Pulmonary Disease (COPD), alongside other chronic autoimmune conditions and it is being developed as an oral tablet.
IF Brilacidin works as good if not better than Otezla, then how much will Brilacidin be worth as a treatment for psoriasis, psoriatic arthritis and Crohn's disease and IBD, etc???
Good luck and GOD bless,
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM